Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for G4690M101 since 12/18/2024, newest first.
| Filer | % of Class | Filed | |
|---|---|---|---|
|
American Century Investment Management, Inc.
13G/A
Amendment 1
|
3.8% |
8/14/2026
Event 6/30/2026
|
|
| American Century Investment Management, Inc. | 3.8% | ||
| American Century Companies, Inc. | 3.8% | ||
| Stowers Institute for Medical Research | 3.8% | ||
|
American Century Investment Management, Inc.
13G
|
5.1%
Checked 5% or less
|
5/1/2026
Event 3/31/2026
|
|
| American Century Investment Management, Inc. | 5.1% | ||
| American Century Companies, Inc. | 5.1% | ||
| Stowers Institute for Medical Research | 5.1% | ||
|
American Century Investment Management, Inc.
13G/A
Amendment 5
|
4.4% |
11/14/2025
Event 9/30/2025
|
|
| American Century Capital Portfolios, Inc. | 1.2% | ||
| American Century Investment Management, Inc. | 4.4% | ||
| American Century Companies, Inc. | 4.4% | ||
| Stowers Institute for Medical Research | 4.4% | ||
| JPMorgan Chase & Co 13G/A Amendment 1 | 2.9% |
5/5/2025
Event 4/30/2025
|
|
| JPMorgan Chase & Co 13G | 5.1% |
4/29/2025
Event 3/31/2025
|
|
|
PineBridge GEM II G.P., L.P.
13D/A
Amendment 7
|
3.9% |
2/27/2025
Event 2/25/2025
|
|
| PineBridge Global Emerging Markets Partners II, L.P. | 3.9% | ||
| PineBridge GEM II G.P., L.P. | 3.9% | ||
| Leone John | 3.9% | ||
| Mellinger Pierre | 3.9% | ||
| Clowe Kevin | 3.9% | ||
|
PineBridge GEM II G.P., L.P.
13D/A
Amendment 6
|
8.3% |
2/14/2025
Event 2/12/2025
|
|
| PineBridge Global Emerging Markets Partners II, L.P. | 8.3% | ||
| PineBridge GEM II G.P., L.P. | 8.3% | ||
| Leone John | 8.3% | ||
| Mellinger Pierre | 8.3% | ||
| Clowe Kevin | 8.3% | ||
|
American Century Investment Management, Inc.
13G/A
Amendment 4
|
5.6% |
2/14/2025
Event 12/31/2024
|
|
| American Century Capital Portfolios, Inc. | 3.2% | ||
| American Century Investment Management, Inc. | 5.6% | ||
| American Century Companies, Inc. | 5.6% | ||
| Stowers Institute for Medical Research | 5.6% | ||
|
PineBridge GEM II G.P., L.P.
13D/A
Amendment 5
|
9.5% |
1/7/2025
Event 1/3/2025
|
|
| PineBridge Global Emerging Markets Partners II, L.P. | 9.5% | ||
| PineBridge GEM II G.P., L.P. | 9.5% | ||
| Leone John | 9.5% | ||
| Mellinger Pierre | 9.5% | ||
| Clowe Kevin | 9.5% |
| Period | Filings | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q3 | 8 | 6.71 k | $297 k |
| 2026 Q2 | 155 | 10.4 M | $317 M |
| 2026 Q1 | 169 | 10.4 M | $278 M |
| 2025 Q4 | 173 | 10.3 M | $392 M |
| 2025 Q3 | 159 | 10.5 M | $423 M |
| 2025 Q2 | 145 | 10.1 M | $295 M |
| 2025 Q1 | 148 | 9.96 M | $242 M |
| 2024 Q4 | 121 | 8.15 M | $175 M |
| 2024 Q3 | 99 | 6.59 M | $131 M |
| 2024 Q2 | 75 | 6.57 M | $106 M |
| 2024 Q1 | 80 | 6.60 M | $102 M |
| 2023 Q4 | 87 | 12.4 M | $227 M |
| 2023 Q3 | 87 | 6.53 M | $101 M |
| 2023 Q2 | 95 | 6.56 M | $139 M |
| 2023 Q1 | 90 | 6.23 M | $151 M |
| 2022 Q4 | 68 | 5.44 M | $135 M |
| 2022 Q3 | 47 | 4.93 M | $91.5 M |
| 2022 Q2 | 47 | 4.84 M | $81.7 M |
| 2022 Q1 | 45 | 4.85 M | $77.1 M |
| 2021 Q4 | 42 | 4.96 M | $64.0 M |
| 2021 Q3 | 40 | 4.56 M | $77.5 M |
| 2021 Q2 | 40 | 4.46 M | $87.0 M |
| 2021 Q1 | 41 | 4.38 M | $96.3 M |
| 2020 Q4 | 43 | 4.40 M | $82.3 M |
| 2020 Q3 | 37 | 4.27 M | $65.6 M |